Cholinesterase inhibitor use is associated with increased plasma levels of anti-Abeta 1–42 antibodies in Alzheimer's disease patients

出版年份 2010 全文链接

标题

作者

关键词

出版物

Volume 486, Issue 3, Pages 193-196

出版商

Elsevier BV

发表日期

2010-09-24

DOI

10.1016/j.neulet.2010.09.050

Discuss science. Find collaborators. Network.

Join a conversation

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now